Report cover image

Global Paget’s disease Treatment Market Size study & Forecast, by Type (Bisphosphonates, Calcitonin Analogues (Salmon Calcitonin), Analgesics, Calcium, and Vitamin D Supplements), Route of Administration (Oral, Intravenous, and Topical), and End User (Hos

Publisher Bizwit Research & Consulting
Published Feb 27, 2023
Length 200 Pages
SKU # BIZW17800714

Description

Global Paget’s disease Treatment Market Size study & Forecast, by Type (Bisphosphonates, Calcitonin Analogues (Salmon Calcitonin), Analgesics, Calcium, and Vitamin D Supplements), Route of Administration (Oral, Intravenous, and Topical), and End User (Hospitals, Clinics, and Others) and Regional Analysis, 2022-2029

Global Paget’s disease Treatment Market is valued approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Paget’s disease, also called Osteitis deformans is a chronic bone disorder that largely occurs in pelvis, skull, spine, and legs. This condition can affect one bone or several bones. The most common symptoms are bone or joint pain. Other symptoms include swelling of joints, tenderness, or redness of the skin. The increasing prevalence of Paget’s disease and the growing number of governments sponsored awareness programs are key factors driving the market growth.

The increasing incidences of Paget’s disease is driving the global Market growth. For instance – as per National Center for Biotechnology Information – around 3 million U.S. citizen are affected by Paget’s bone disease. Moreover, as per National Organization for rare disease estimates - prevalence of Paget’s disease in the United States is estimated as 1-2 percent of the general population. Also, rise in geriatric population and growing R&D activities in healthcare sector would create lucrative growth prospectus for the market over the forecast period. However, the high cost of Paget’s disease Treatment and patent expiry of certain drugs stifle the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Paget’s disease Treatment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of Paget’s disease of bone and growing healthcare expenditure in the region. Whereas Asia Pacific is expected to grow with a highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and increasing awareness towards available treatment options for Paget’s disease in the region.

Major market player included in this report are:
Pfizer Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Mylan NV
Neopharma Inc.
Allergan
Sanofi S.A.
Fresenius Kabi
Mallinckrodt Pharmaceuticals
Sun Pharmaceutical Industries Ltd.

Recent Developments:
 In March 2022, Sanofi and IGM Biosciences, Inc. announced t an exclusive worldwide collaboration agreement to create, develop, manufacture, and commercialize IgM antibody agonists against three oncology targets and three immunology/inflammation targets

Global Paget’s disease Treatment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Type, Route of Administration, End User, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Type
Bisphosphonates
Calcitonin Analogues (Salmon Calcitonin)
Analgesics
Calcium
Vitamin D Supplements
By Route of Administration
Oral
Intravenous
Topical
By End User
Hospitals
Clinics
Others

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Pfizer Inc.
Novartis AG
Teva Pharmaceutical Industries Ltd.
Mylan NV
Neopharma Inc.
Allergan
Sanofi S.A.
Fresenius Kabi
Mallinckrodt Pharmaceuticals
Sun Pharmaceutical Industries Ltd.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.

Table of Contents

200 Pages
Chapter 1. Executive Summary
1.1. Market Snapshot
1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
1.2.1. Paget’s disease Treatment Market, by Region, 2019-2029 (USD Billion)
1.2.2. Paget’s disease Treatment Market, by Type, 2019-2029 (USD Billion)
1.2.3. Paget’s disease Treatment Market, by Route of Administration, 2019-2029 (USD Billion)
1.2.4. Paget’s disease Treatment Market, by End User, 2019-2029 (USD Billion)
1.3. Key Trends
1.4. Estimation Methodology
1.5. Research Assumption
Chapter 2. Global Paget’s disease Treatment Market Definition and Scope
2.1. Objective of the Study
2.2. Market Definition & Scope
2.2.1. Scope of the Study
2.2.2. Industry Evolution
2.3. Years Considered for the Study
2.4. Currency Conversion Rates
Chapter 3. Global Paget’s disease Treatment Market Dynamics
3.1. Paget’s disease Treatment Market Impact Analysis (2019-2029)
3.1.1. Market Drivers
3.1.1.1. Increasing prevalence of Paget’s disease
3.1.1.2. Growing number of governments sponsored awareness programme
3.1.2. Market Challenges
3.1.2.1. Patent expiry of certain drugs
3.1.3. Market Opportunities
3.1.3.1. Rise in geriatric population
3.1.3.2. Growing R&D activities in healthcare sector
Chapter 4. Global Paget’s disease Treatment Market Industry Analysis
4.1. Porter’s 5 Force Model
4.1.1. Bargaining Power of Suppliers
4.1.2. Bargaining Power of Buyers
4.1.3. Threat of New Entrants
4.1.4. Threat of Substitutes
4.1.5. Competitive Rivalry
4.2. Futuristic Approach to Porter’s 5 Force Model (2019-2029)
4.3. PEST Analysis
4.3.1. Political
4.3.2. Economical
4.3.3. Social
4.3.4. Technological
4.4. Top investment opportunity
4.5. Top winning strategies
4.6. Industry Experts Prospective
4.7. Analyst Recommendation & Conclusion
Chapter 5. Risk Assessment: COVID-19 Impact
5.1. Assessment of the overall impact of COVID-19 on the industry
5.2. Pre COVID-19 and post COVID-19 Market scenario
Chapter 6. Global Paget’s disease Treatment Market, by Type
6.1. Market Snapshot
6.2. Global Paget’s disease Treatment Market by Type, Performance - Potential Analysis
6.3. Global Paget’s disease Treatment Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
6.4. Paget’s disease Treatment Market, Sub Segment Analysis
6.4.1. Bisphosphonates
6.4.2. Calcitonin Analogues (Salmon Calcitonin)
6.4.3. Analgesics
6.4.4. Calcium
6.4.5. Vitamin D Supplements
Chapter 7. Global Paget’s disease Treatment Market, by Route of Administration
7.1. Market Snapshot
7.2. Global Paget’s disease Treatment Market by Route of Administration, Performance - Potential Analysis
7.3. Global Paget’s disease Treatment Market Estimates & Forecasts by Route of Administration 2019-2029 (USD Billion)
7.4. Paget’s disease Treatment Market, Sub Segment Analysis
7.4.1. Oral
7.4.2. Intravenous
7.4.3. Topical
Chapter 8. Global Paget’s disease Treatment Market, by End User
8.1. Market Snapshot
8.2. Global Paget’s disease Treatment Market by End User, Performance - Potential Analysis
8.3. Global Paget’s disease Treatment Market Estimates & Forecasts by End User 2019-2029 (USD Billion)
8.4. Paget’s disease Treatment Market, Sub Segment Analysis
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Others
Chapter 9. Global Paget’s disease Treatment Market, Regional Analysis
9.1. Paget’s disease Treatment Market, Regional Market Snapshot
9.2. North America Paget’s disease Treatment Market
9.2.1. U.S. Paget’s disease Treatment Market
9.2.1.1. Type breakdown estimates & forecasts, 2019-2029
9.2.1.2. Route of Administration breakdown estimates & forecasts, 2019-2029
9.2.1.3. End User breakdown estimates & forecasts, 2019-2029
9.2.2. Canada Paget’s disease Treatment Market
9.3. Europe Paget’s disease Treatment Market Snapshot
9.3.1. U.K. Paget’s disease Treatment Market
9.3.2. Germany Paget’s disease Treatment Market
9.3.3. France Paget’s disease Treatment Market
9.3.4. Spain Paget’s disease Treatment Market
9.3.5. Italy Paget’s disease Treatment Market
9.3.6. Rest of Europe Paget’s disease Treatment Market
9.4. Asia-Pacific Paget’s disease Treatment Market Snapshot
9.4.1. China Paget’s disease Treatment Market
9.4.2. India Paget’s disease Treatment Market
9.4.3. Japan Paget’s disease Treatment Market
9.4.4. Australia Paget’s disease Treatment Market
9.4.5. South Korea Paget’s disease Treatment Market
9.4.6. Rest of Asia Pacific Paget’s disease Treatment Market
9.5. Latin America Paget’s disease Treatment Market Snapshot
9.5.1. Brazil Paget’s disease Treatment Market
9.5.2. Mexico Paget’s disease Treatment Market
9.5.3. Rest of Latin America Paget’s disease Treatment Market
9.6. Rest of The World Paget’s disease Treatment Market
Chapter 10. Competitive Intelligence
10.1. Top Market Strategies
10.2. Company Profiles
10.2.1. Pfizer Inc.
10.2.1.1. Key Information
10.2.1.2. Overview
10.2.1.3. Financial (Subject to Data Availability)
10.2.1.4. Product Summary
10.2.1.5. Recent Developments
10.2.2. Novartis AG
10.2.3. Teva Pharmaceutical Industries Ltd.
10.2.4. Mylan NV
10.2.5. Neopharma Inc.
10.2.6. Allergan
10.2.7. Sanofi S.A.
10.2.8. Fresenius Kabi
10.2.9. Mallinckrodt Pharmaceuticals
10.2.10. Sun Pharmaceutical Industries Ltd.
Chapter 11. Research Process
11.1. Research Process
11.1.1. Data Mining
11.1.2. Analysis
11.1.3. Market Estimation
11.1.4. Validation
11.1.5. Publishing
11.2. Research Attributes
11.3. Research Assumption
List of Tables
TABLE 1. Global Paget’s disease Treatment Market, report scope
TABLE 2. Global Paget’s disease Treatment Market estimates & forecasts by Region 2019-2029 (USD Billion)
TABLE 3. Global Paget’s disease Treatment Market estimates & forecasts by Type 2019-2029 (USD Billion)
TABLE 4. Global Paget’s disease Treatment Market estimates & forecasts by Route of Administration 2019-2029 (USD Billion)
TABLE 5. Global Paget’s disease Treatment Market estimates & forecasts by End User 2019-2029 (USD Billion)
TABLE 6. Global Paget’s disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 7. Global Paget’s disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 8. Global Paget’s disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 9. Global Paget’s disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 10. Global Paget’s disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 11. Global Paget’s disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 12. Global Paget’s disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 13. Global Paget’s disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 14. Global Paget’s disease Treatment Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 15. Global Paget’s disease Treatment Market by region, estimates & forecasts, 2019-2029 (USD Billion)
TABLE 16. U.S. Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 17. U.S. Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 18. U.S. Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 19. Canada Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 20. Canada Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 21. Canada Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 22. UK Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 23. UK Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 24. UK Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 25. Germany Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 26. Germany Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 27. Germany Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 28. France Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 29. France Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 30. France Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 31. Italy Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 32. Italy Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 33. Italy Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 34. Spain Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 35. Spain Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 36. Spain Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 37. RoE Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 38. RoE Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 39. RoE Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 40. China Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 41. China Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 42. China Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 43. India Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 44. India Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 45. India Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 46. Japan Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 47. Japan Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 48. Japan Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 49. South Korea Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 50. South Korea Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 51. South Korea Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 52. Australia Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 53. Australia Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 54. Australia Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 55. RoAPAC Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 56. RoAPAC Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 57. RoAPAC Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 58. Brazil Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 59. Brazil Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 60. Brazil Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 61. Mexico Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 62. Mexico Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 63. Mexico Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 64. RoLA Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 65. RoLA Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 66. RoLA Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 67. Row Paget’s disease Treatment Market estimates & forecasts, 2019-2029 (USD Billion)
TABLE 68. Row Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 69. Row Paget’s disease Treatment Market estimates & forecasts by segment 2019-2029 (USD Billion)
TABLE 70. List of secondary sources, used in the study of global Paget’s disease Treatment Market
TABLE 71. List of primary sources, used in the study of global Paget’s disease Treatment Market
TABLE 72. Years considered for the study
TABLE 73. Exchange rates considered
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
FIGURES 1. Global Paget’s disease Treatment Market, research methodology
FIGURES 2. Global Paget’s disease Treatment Market, Market estimation techniques
FIGURES 3. Global Market size estimates & forecast methods
FIGURES 4. Global Paget’s disease Treatment Market, key trends 2021
FIGURES 5. Global Paget’s disease Treatment Market, growth prospects 2022-2029
FIGURES 6. Global Paget’s disease Treatment Market, porters 5 force model
FIGURES 7. Global Paget’s disease Treatment Market, pest analysis
FIGURES 8. Global Paget’s disease Treatment Market, value chain analysis
FIGURES 9. Global Paget’s disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIGURES 10. Global Paget’s disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIGURES 11. Global Paget’s disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIGURES 12. Global Paget’s disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIGURES 13. Global Paget’s disease Treatment Market by segment, 2019 & 2029 (USD Billion)
FIGURES 14. Global Paget’s disease Treatment Market, regional snapshot 2019 & 2029
FIGURES 15. North America Paget’s disease Treatment Market 2019 & 2029 (USD Billion)
FIGURES 16. Europe Paget’s disease Treatment Market 2019 & 2029 (USD Billion)
FIGURES 17. Asia pacific Paget’s disease Treatment Market 2019 & 2029 (USD Billion)
FIGURES 18. Latin America Paget’s disease Treatment Market 2019 & 2029 (USD Billion)
FIGURES 19. Global Paget’s disease Treatment Market, company Market share analysis (2021)
List of tables and figures and dummy in nature, final lists may vary in the final deliverable

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us